Heart bypass patients may get a cheap pill to save their new vessels
NCT ID NCT07569328
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study tests whether taking a low-dose colchicine pill every day after heart bypass surgery can prevent the new blood vessels from failing. About 622 adults with coronary artery disease will receive either colchicine or a placebo for 24 months. The main goal is to see if colchicine reduces the rate of graft failure, which is checked with a special CT scan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CABG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital
Beijing, Beijing Municipality, 100029, China
Conditions
Explore the condition pages connected to this study.